Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.14 by 8.77 percent. This is a 3000 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $412.00 million which beat the analyst consensus estimate of $409.09 million by 0.71 percent. This is a 32.05 percent increase over sales of $312.00 million the same period last year.
Yeyian Gaming Signs Distribution Agreement With TD SYNNEX; Under The Terms Of The Deal, TD SYNNEX Will Distribute A Wide Range Of Yeyian Gaming Products To Resellers Nationwide Beginning In October 2022
Yeyian announced a new distribution agreement with TD SYNNEX, a leading distributor and solutions aggregator for the IT ecosystem. Under the terms of the deal, TD SYNNEX will distribute a wide range of Yeyian Gaming
